Prometic logo with the wordmark in blue geometric sans-serif letters.
Embed

ProMetic

ProMetic Life Sciences Inc. was a Canadian biopharmaceutical company headquartered in Laval, Quebec, that used the ProMetic name from 1998 until October 2019, when it rebranded as Liminal BioSciences Inc. Its identity was a typographic wordmark.

ProMetic Life Sciences Inc. was a Canadian biopharmaceutical company headquartered in Laval, Quebec, that operated under the ProMetic name from 1998 until October 2019, when it rebranded as Liminal BioSciences Inc. [1] [2] The company’s visual identity during this period consisted of a typographic wordmark, a format that placed the brand name at the center of the identity.

Design and History

ProMetic was incorporated on October 14, 1994 under the Canada Business Corporations Act as Innovon Life Sciences Holdings Limited. On May 19, 1998, the corporation changed its name to Prometic Life Sciences Inc. [1] The company’s official filings list “Prometic™” as a registered or unregistered trademark of the corporation. [1]

In September 2019, ProMetic announced its intention to change its name as part of a global rebrand in support of its new vision and values. [3] On October 3, 2019, shareholders representing approximately 87% of votes cast approved the special resolution to change the company’s name to Liminal BioSciences Inc. [2] The name change took effect in October 2019, and the company’s common shares began trading on the Toronto Stock Exchange under the symbol “LMNL” on or about October 7, 2019. [2]

The rebrand to Liminal BioSciences was tied to the company’s strategic shift and its application for a NASDAQ listing, which the company described as an appropriate time for the name change. [3] The new website at www.liminalbiosciences.com was launched concurrently with the name change. [2]

Meaning and Symbolism

Documented symbolism for the ProMetic wordmark itself is limited. The company’s official filings describe the ProMetic name as a trademark but do not elaborate on the meaning or symbolism of the logo’s design elements. [1] The rebrand to Liminal BioSciences was described by CEO Kenneth Galbraith as reflecting “the Company’s new vision and values,” though the press release does not specify the visual design of the new identity. [3]

Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.

Logo data

Measured from the original SVG file on 30/09/2026.

Colors

Single color.

  • #3374C2Blue, 100%

    RGB 51, 116, 194; CMYK 74, 40, 0, 24

    White text 4.8:1 (passes AA)

Copy as

Backgrounds and sizes

Contrast and color difference

Compared with Pharmaceuticals

75 measured Pharmaceuticals logos

  • Main color blue44%
  • Wordmark32%
  • Single color41%

From measured files, not tags. Updated 28/10/2026.

Structure

Logo type
WordmarkClassified by AI
Proportions
6.5 : 1Horizontal
Ink coverage
44%56% empty space inside the outline
Symmetry
Asymmetric28% left-right match
Outline
Free-formOverall silhouette
Complexity
Moderate1 shapes, about 220 points

Tints and shades

Click a step to copy

#3374C2

Typography

Lettering style: Geometric sans.

This is a style class, not the exact font. The font has not been documented.

Free fonts in this style: Montserrat, Outfit, Urbanist

Visual description

Classified by AI

Style
Minimal, corporate
Layout
Lettering on its own
Text in the logo
Prometic

Cite or embed

Similar Logos

Report a problem